« Return to News | R&D Trends

ALS Association announces $4M in research grants for Lou Gehrig's disease

Friday, August 10, 2012 11:43 AM

The ALS Association has awarded $4 million in research grants to researchers in 31 laboratories across the U.S., U.K., Belgium, Germany and Canada to find treatments and a cure for Lou Gehrig's disease (ALS)

The awards are part of ALS Association’s Translational Research Advancing Therapies for ALS (TREAT ALS) program, through which the Association funds a diverse portfolio of research on the progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord.

"We are very pleased to announce these new research grants to some of the most promising ALS researchers in the U.S. and around the world," said Lucie Bruijn, Ph.D., chief scientist for the ALS Association. "The ALS Association looks forward to sharing the results of these diverse studies, which we hope will provide pieces to the complex puzzle of this devastating disease."

The Association offers both investigator-initiated awards, for research proposed by the scientists themselves, and ALS Association-initiated awards, for research proposals in areas identified by the Association and its scientific advisors as key targets for new research. The Association also offers the Milton Safenowitz Post-Doctoral Fellowship for ALS Research Award—funding two years of research and encouraging young scientists to enter the ALS field.

These grants will fund research that includes work in cell and animal model systems, genetics, environmental investigations, and work directly with people with ALS.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.